← FDA DRUG APPROVALS

FDA ANDA · ANDA083186

PROPOXYPHENE HYDROCHLORIDE

Sponsor: MUTUAL PHARM

APPLICATION
ANDA083186
TYPE
ANDA
ORIGINAL APPROVAL
1972-12-18
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PROPOXYPHENE HYDROCHLORIDEDiscontinued
PROPOXYPHENE HYDROCHLORIDE 65MG · CAPSULE · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 45AP
1994-12-23Manufacturing (CMC) · Supplement 44AP
1992-04-03Manufacturing (CMC) · Supplement 43AP
1992-04-03Manufacturing (CMC) · Supplement 41AP
1987-04-10Manufacturing (CMC) · Supplement 40AP
1972-12-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →